Drug intelligence / Profile preview

rhizoma arisaemetis preparata

Development stage
Unknown
Lead developer
Obstetrics and Gynecology Hospital of Fudan University
Administration
Oral, Topical
01

Overview

Rhizoma Arisaemetis Preparata, known in Traditional Chinese Medicine (TCM) as **Zhi Tian Nan Xing**, is a processed herbal preparation derived from the tubers of *Arisaema* species, such as *Arisaema erubescens*, *Arisaema heterophyllum*, or *Arisaema amurense*. The raw herb is naturally toxic and acrid; therefore, it is typically processed with ginger juice and alum to mitigate toxicity and enhance its therapeutic properties. In clinical research, particularly in China, it is being investigated for transvaginal administration to treat persistent high-risk human papillomavirus (HPV) infections and associated lesions like cervical intraepithelial neoplasia (CIN) and vaginal intraepithelial neoplasia (VaIN). Its mechanism of action is thought to involve the induction of apoptosis in HPV-infected cells and the modulation of the local immune microenvironment, although specific molecular targets are not fully characterized in standard Western pharmacology.

Other names
制天南星Zhi Tian Nan Xingprocessed Arisaema tuberRhizoma Arisaematis PreparatumRhizoma Arisaematis Preparata
02

Targets

AKT (RAC-alpha serine/threonine-protein kinase)IL1B (Interleukin-1 beta)TNFA (Tumor necrosis factor alpha (soluble))STAT3 (Signal Transducer and Activator of Transcription 3)ESR1 (ERα)

Beyond the preview

Go deeper on rhizoma arisaemetis preparata.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on rhizoma arisaemetis preparata.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call